David Sibon

Associate Professor, MD, PhD

Hôpitaux Universitaires Henri-Mondor

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Javeed Iqbal

Professor,

University of Nebraska Medical Center

UNITED STATES

View details

Aurélien Belot

Assisstant Professor in Medical Statistics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Marie‐Helene Delfau‐Larue

FRANCE

View details

Jean‐Marie Michot

FRANCE

View details

Gandhi Damaj

University Hospital

FRANCE

View details

B. Deau

FRANCE

View details

Olivier Casasnovas

FRANCE

View details

Isabelle Demeestere

Université libre de Bruxelles

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Sibon

Research Interests

Explore related searches

Contact this professor

Articles (10)

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA

Do we have to exclude all relapsed diffuse large B‐cell lymphoma patients not in complete remission from autologous stem cell transplant?

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA

Peripheral T-Cell Lymphomas: Therapeutic Approaches

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Minimal Residual Disease Monitoring Using a 3 ' ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR

Collaborators (8)

Javeed Iqbal

Aurélien Belot

Marie‐Helene Delfau‐Larue

Jean‐Marie Michot

Gandhi Damaj

B. Deau

Olivier Casasnovas

Isabelle Demeestere

Make your next move.